Speaker illustration

Doctor Marta Banaszkiewicz

European Health Centre, Otwock (Poland)

Member of:

European Society of Cardiology

Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension?

Event: ESC Congress 2017

Topic: Chronic pulmonary hypertension

Session: Pulmonary hypertension, congenital and acquired

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb